Publication: Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 Brazilian cases
This research article, published in Molecular Genetics and Metabolism Reports, evaluates and validates 3-O-methyldopa (3-OMD) as a biomarker for aromatic L-amino acid decarboxylase (AADC) deficiency
Learn about the validation of 3-OMD as a reliable and stable marker for the identification of AADC deficiency, using dried blood spot (DBS) samples of 7 AADC deficiency patients and 35 non-AADC deficiency controls
Understand the limitations of current diagnostic tests for AADC deficiency
Recognize the potential utility of 3-OMD quantification performed in DBS’ in newborn screening
Kubaski F, et al. Mol Genet Metab Rep. 2021;27:100744
Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.
Register now to unlock the content
Register now to access the content on this page
Already registered?
If not, register below
US-AADC-0497 | August 2023
Sign in or register to access exclusive content on this site
Register here to access the content on the site US-CORP-0330 | July 2022
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.